l 753037 has been researched along with endothelin-1 in 8 studies
| Studies (l 753037) | Trials (l 753037) | Recent Studies (post-2010) (l 753037) | Studies (endothelin-1) | Trials (endothelin-1) | Recent Studies (post-2010) (endothelin-1) |
|---|---|---|---|---|---|
| 18 | 1 | 1 | 12,740 | 632 | 3,394 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayton, F; Fukuroda, T; Gabel, R; Hara, K; Hayama, T; Ishikawa, K; Kamei, T; Kanoh, T; Kivlighn, S; Krause, S; Lynch, J; Nishikibe, M; Noguchi, K; Nolan, N; O'Brien, J; Ohta, H; Okada, M; Ozaki, S; Pettibone, D; Saito, M; Siegl, P; William, D; Zingaro, G | 1 |
| Ikeda, T; Kawai, N; Kobayashi, T; Maeda, S; Miyauchi, T; Nakao, R; Nishikibe, M; Ohta, H; Okada, M; Siegl, PK | 1 |
| Ikeda, T; Kawai, N; Kobayashi, T; Miyauchi, T; Nakao, R; Nishikibe, M; Ohta, H; Okada, M; Siegl, PK | 1 |
| Abraham, WT; Lamba, S; Suresh, DP | 1 |
| Hanada, K; Miyauchi, T; Nakao, M; Nakao, R; Nishikibe, M; Ohta, H; Suzuki, J; Tadano, K; Uehara, S | 1 |
| Kamata, K; Kanie, N; Kobayashi, T; Matsumoto, T | 1 |
| Gebb, SA; Homma, N; Karoor, V; McMurtry, IF; Morio, Y; Nagaoka, T; Oka, M; Ota, H | 1 |
| Kimura, K; Kitada, K; Koyama, M; Matsumura, Y; Mori, T; Ohkita, M; Suzuki, R; Tanaka, R; Yui, N | 1 |
1 review(s) available for l 753037 and endothelin-1
| Article | Year |
|---|---|
New developments in heart failure: role of endothelin and the use of endothelin receptor antagonists.
Topics: Bosentan; Carboxylic Acids; Chronic Disease; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Indans; Peptides, Cyclic; Prognosis; Pyridines; Pyrimidines; Receptors, Endothelin; Sulfonamides; Treatment Outcome | 2000 |
7 other study(ies) available for l 753037 and endothelin-1
| Article | Year |
|---|---|
Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
Topics: Animals; Binding, Competitive; Blood Pressure; CHO Cells; Cloning, Molecular; Cricetinae; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Female; Hippocampus; Humans; Iliac Artery; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle, Smooth, Vascular; Phosphatidylinositols; Pulmonary Artery; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Recombinant Proteins; Renal Artery; Transfection; Uterus | 1999 |
Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension.
Topics: Animals; Aorta; Blood Pressure; Endothelin Receptor Antagonists; Endothelin-1; Heart Ventricles; Hypertension; Kidney; Male; Myocardium; Pressoreceptors; Pyridines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Ventricular Function, Left | 1999 |
Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Drug Synergism; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Losartan; Male; Protein Precursors; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger | 2000 |
Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Pacing, Artificial; Chronic Disease; Dogs; Echocardiography; Enalaprilat; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Hemodynamics; Pyridines; Receptors, Endothelin; Tissue Distribution; Ventricular Function | 2001 |
Endothelin-1-induced impairment of endothelium-dependent relaxation in aortas isolated from controls and diabetic rats.
Topics: Acetylcholine; Animals; Aorta; Chromones; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Free Radical Scavengers; Male; Morpholines; Nitroprusside; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Polyethylene Glycols; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Wistar; Receptors, Endothelin; Superoxide Dismutase; Superoxides; Tissue Culture Techniques; Vasodilation; Vasodilator Agents | 2004 |
Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
Topics: Amides; Animals; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Enzyme Activation; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Lung; Male; Peptides, Cyclic; Perfusion; Potassium Chloride; Pulmonary Artery; Pulmonary Circulation; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Serotonin; Signal Transduction; Vasoconstriction | 2007 |
Endothelin ETB receptor is involved in sex differences in the development of balloon injury-induced neointimal formation.
Topics: Animals; Catheterization; Endothelin-1; Estrogens; Female; Male; Neointima; Ovariectomy; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sex Characteristics; Systole | 2011 |